Details for Patent: 10,953,112
✉ Email this page to a colleague
Which drugs does patent 10,953,112 protect, and when does it expire?
Patent 10,953,112 protects AXUMIN and is included in one NDA.
This patent has twenty-nine patent family members in sixteen countries.
Summary for Patent: 10,953,112
| Title: | Precursor compound of radioactive halogen-labeled organic compound |
| Abstract: | It is intended to provide a novel amino acid organic compound which can be used as a labeling precursor compound for radioactive halogen-labeled amino acid compounds including [.sup.18F]FACBC, and which prevents methanol from remaining in the radioactive halogen-labeled amino acid compounds produced therefrom. The novel amino acid organic compound is a compound represented by the following formula: ##STR00001## wherein n is an integer of 0 or of 1 to 4; R.sup.1 is an ethyl, 1-propyl or isopropyl substituent; X is a halogen substituent or a group represented by --OR.sup.2; R.sup.2 is a straight-chain or branched-chain haloalkylsulfonic acid substituent with one to 10 carbon atoms, trialkylstannyl substituent with 3 to 12 carbon atoms, fluorosulfonic acid substituent or aromatic sulfonic acid substituent; and R.sup.3 is a protective group. |
| Inventor(s): | Ito; Osamu (Chiba, JP), Hayashi; Akio (Chiba, JP), Kurosaki; Fumie (Chiba, JP), Toyama; Masahito (Chiba, JP), Shinmura; Toshiyuki (Chiba, JP), Harano; Arinori (Chiba, JP) |
| Assignee: | NIHON MEDI-PHYSICS CO., LTD. (Tokyo, JP) |
| Application Number: | 16/852,910 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,953,112
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | AXUMIN | fluciclovine f-18 | SOLUTION;INTRAVENOUS | 208054-001 | May 27, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF DIAGNOSING TUMORS USING POSITRON EMISSION TOMOGRAPHY | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,953,112
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2005-343653 | Nov 29, 2005 |
International Family Members for US Patent 10,953,112
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006319987 | ⤷ Try a Trial | |||
| Brazil | PI0619213 | ⤷ Try a Trial | |||
| Canada | 2629227 | ⤷ Try a Trial | |||
| China | 101316812 | ⤷ Try a Trial | |||
| European Patent Office | 1978015 | ⤷ Try a Trial | |||
| European Patent Office | 3354639 | ⤷ Try a Trial | |||
| Spain | 2663496 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
